Actualización en el tratamiento del herpes genital

Severson, 1999, Relation between herpes simplex viruses and human immunodeficiency virus infections, Arch Dermatol, 135, 1393, 10.1001/archderm.135.11.1393 Milpied, 2006, Herpes genital, Ann Dermatol Venereol, 133, S28, 10.1016/S0151-9638(06)71017-1 Fleming, 1997, Herpes simplex virus type 2 in the United States, 1976-1994, N Engl J Med, 337, 1105, 10.1056/NEJM199710163371601 Velasco, 2007, Actualización del herpes genital Mertz, 1992, Risk factors for the sexual transmission of genital herpes, Ann Intern Med, 116, 197, 10.7326/0003-4819-116-3-197 Ferrán, 2006, Tratamiento del herpes zóster, Actas Dermosifiliogr, 97, 25 España, 2006, Actualización en el tratamiento del herpes zóster, Actas Dermosifiliogr, 97, 103, 10.1016/S0001-7310(06)73360-9 McKendrick, 1986, Oral acyclovir in acute herpes zoster, Br Med J, 293, 1529, 10.1136/bmj.293.6561.1529 Beutner, 1995, Valaciclovir compared with acyclovir for improved therapy for herpes zoster in immunocompetent adults, Antimicrobiol Agents Chemother, 39, 1546, 10.1128/AAC.39.7.1546 Perry, 1996, Valaciclovir: A review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy in herpesvirus infections, Drugs, 52, 754, 10.2165/00003495-199652050-00009 Earnshaw, 1992, Mode of antiviral action of penciclovir in MRC-5 cells infected with herpes simplex virus type 1 (HSV-1), HSV-2, and varicella-zoster virus, Antimicrob Agents Chemother, 36, 2747, 10.1128/AAC.36.12.2747 Centers for Disease Control and Prevention, 2006, Sexually transmitted diseases treatment guidelines, 2006, MMWR, 55, 16 Ashley, 1999, Herpes genital: review of the epidemic and potential use of type-specific serology, Clin Microbiol Rev, 12, 1, 10.1128/CMR.12.1.1 Tyring, 2007, Single-day therapy: an expert opinion on a recent development for the episodic treatment of recurrent genital herpes, Arch Gynecol Obstet, 275, 1, 10.1007/s00404-006-0234-z Corey, 2004, Once-daily valacyclovir to reduce the risk of transmission of genital herpes, N Engl J Med, 350, 11, 10.1056/NEJMoa035144 Fife, 2006, Effect of valacyclovir on viral shedding in immunocompetent patients with recurrent herpes simplex virus 2 genital herpes: a US-based randomized, double-blind, placebo-controlled clinical trial, Mayo Clin Proc, 81, 1321, 10.4065/81.10.1321 Wald, 2006, Comparative efficacy of famciclovir and valacyclovir for suppression of recurrent genital herpes and virus shedding, Sex Transm Dis, 33, 529, 10.1097/01.olq.0000204723.15765.91 Díaz-Mitoma, 1998, Oral famciclovir for the suppression of recurrent genital herpes: a randomized controlled trial, JAMA, 280, 887, 10.1001/jama.280.10.887 Reitano, 1998, Valacyclovir for the suppression of recurrent genital herpes simplex virus infection: a large-scale dose range-finding study, J Infect Dis, 178, 603, 10.1086/515385 Sacks, 1996, Patient-initiated, twice-daily oral famciclovir for early recurrent genital herpes, JAMA, 276, 44, 10.1001/jama.1996.03540010046029 Whitley, 2006, New approaches to the therapy of HVS infections, Herpes, 13, 2 Pue, 1993, Pharmacokinetics of famciclovir in man, Antivir Chem Chemother, 4, 47, 10.1177/09563202930040S602 Spruance, 2006, Single-dose, patient-initiated famciclovir: a randomized, double-blind, placebo-controlled trial for episodic treatment of herpes labialis, J Am Acad Dermatol, 55, 47, 10.1016/j.jaad.2006.02.031 Spruance, 2007, Short-course therapy for recurrent genital herpes and herpes labialis, J Fam Pract, 56, 30 Aoki, 2006, Single-day, patient-initiated famciclovir therapy for recurrent genital herpes: a randomized, double-blind, placebo-controlled trial, Clin Infect Dis, 42, 8, 10.1086/498521 Whitley, 2006, Single-day famciclovir therapy for recurrent genital herpes, Curr Med Res Opin, 22, 1307, 10.1185/030079906X112642 Vinh, 2006, Famciclovir for the treatment of recurrent genital herpes: a clinical and pharmacological perspective, Expert Opin Pharmacother, 7, 2271, 10.1517/14656566.7.16.2271 Simpson, 2006, Famciclovir: a review of its use in herpes zoster and genital and orolabial herpes, Drugs, 6, 2397, 10.2165/00003495-200666180-00016 Reichman, 1984, Treatment of recurrent genital herpes simplex infections with oral acyclovir. A controlled trial, JAMA, 251, 2103, 10.1001/jama.1984.03340400031020 Fife, 2007, A comparison of one year of episodic or suppressive treatment of recurrent genital herpes with valacyclovir, Sex Trasm Dis, 34, 297, 10.1097/01.olq.0000237853.69443.71 Brown, 2005, Genital herpes complicating pregnancy, Obstet Gynecol, 106, 845, 10.1097/01.AOG.0000180779.35572.3a Del Boz, 2008, Herpes simple zosteriforme neonatal, Actas Dermosifiliogr, 99, 157, 10.1016/S0001-7310(08)74648-9 Requena, 2006, Diagnóstico y diagnóstico diferencial del herpes zóster, Actas Dermosifiliogr, 97, 17 Brown, 2004, Preventing herpes simplex virus transmission to the neonate, Herpes, 11, 175A Brown, 1991, Neonatal herpes simplex virus infection in relation to asymptomatic maternal infection at the time of labor, N Engl J Med, 324, 1247, 10.1056/NEJM199105023241804 Brown, 1997, The acquisition of herpes simplex virus during pregnancy, N Engl J Med, 337, 509, 10.1056/NEJM199708213370801 Brown, 2000, HVS-2 specific serology should be offered routinely to antenatal patients, Rev Med Virol, 10, 141, 10.1002/(SICI)1099-1654(200005/06)10:3<141::AID-RMV280>3.0.CO;2-2 Watts, 2003, A double-blind, randomized, placebo-controlled trial of acyclovir in late pregnancy for the reduction of herpes simplex virus shedding and caesarean delivery, Am J Obstet Gynecol, 188, 836, 10.1067/mob.2003.185 Stone, 2004, Pregnancy outcomes following systemic prenatal acyclovir exposure: conclusions from the international acyclovir pregnancy registry, 1984-1989, Birth Defects Research (Part A), 70, 201, 10.1002/bdra.20013 Sheffield, 2003, Acyclovir prophylaxis to prevent herpes simplex virus recurrence at delivery: a systematic review, Obstet Gynecol, 102, 1396 Scott, 2002, Acyclovir suppression to prevent genital recurrent herpes at delivery, Infect Dis Obstet Gynecol, 10, 71, 10.1155/S1064744902000054 Sheffield, 2006, Valacyclovir prophylaxis to prevent recurrent herpes at delivery: a randomized clinical trial, Obstet Gynecol, 108, 141, 10.1097/01.AOG.0000219749.96274.15 Andrews, 2006, Valacyclovir therapy to reduce recurrent genital herpes in pregnant women, Am J Obstet Gynecol, 194, 774, 10.1016/j.ajog.2005.11.051 Fonnest, 1997, Neonatal herpes in Denmark 1977-1991, Acta Obstet Gynecol Scand, 76, 335, 10.1111/j.1600-0412.1997.tb07992.x Kesson, 2001, Management of neonatal herpes simplex virus infection, Paediatr Drugs, 3, 81, 10.2165/00128072-200103020-00001 Scott, 1996, Acyclovir suppression to prevent caesarean delivery after first-episode genital herpes, Obstet Gynecol, 87, 69, 10.1016/0029-7844(95)00357-6 Braig, 2001, Acyclovir prophylaxis in late pregnancy prevents recurrent genital herpes and viral shedding, Eur J Obstet Gynecol Reprod Biol, 96, 55, 10.1016/S0301-2115(00)00406-1 Parvey, 1980, Neonatal herpes simplex virus infection introduced by fetal-monitor scalp electrodes, Pediatrics, 65, 150, 10.1542/peds.65.6.1150 Sauerbrei, 2007, Herpes simplex and varicella-zoster virus infections during pregnancy: current concepts of prevention, diagnosis and therapy. Part 1: Herpes simplex virus infections, Med Microbiol Immunol, 196, 95, 10.1007/s00430-006-0032-z Prober, 1987, Low risk of herpes simplex virus infections in neonates exposed to the virus at the time of vaginal delivery to mothers with recurrent genital herpes simplex virus infections, N Engl J Med, 316, 240, 10.1056/NEJM198701293160503 Libman, 1991, Strategies for the prevention of neonatal infection with herpes simplex virus: a decision analysis, Rev Infect Dis, 13, 1093, 10.1093/clinids/13.6.1093 Hutto, 1987, Intrauterine herpes simplex virus infections, J Pediatr, 110, 97, 10.1016/S0022-3476(87)80298-6 Khaddar, 2005, Genital primary herpetic infection in an infant: clinical features, diagnosis and management, Dermatol Online J, 11, 22, 10.5070/D39102M0S1 Taieb, 1987, Clinical epidemiology of symptomatic primary herpetic infection in children. A study of 50 cases, Acta Paediatr Scand, 76, 128, 10.1111/j.1651-2227.1987.tb10428.x Anderson, 1995, Childhood sexually transmited diseases: one consequence of sexual abuse, Public Health Nurs, 12, 41, 10.1111/j.1525-1446.1995.tb00121.x Bagdades, 1992, Relationship between herpes simplex virus ulceration and CD4 cell counts in patients with HIV infection, AIDS, 6, 1317, 10.1097/00002030-199211000-00012 Strick, 2006, Management of herpes simplex virus type 2 infection in VIH type 1-infected presons, Clin Infect Dis, 43, 347, 10.1086/505496 Mertz, 1993, Epidemiology of genital herpes infections, Infect Dis Clin North Am, 7, 825, 10.1016/S0891-5520(20)30561-4 O’Farrell, 1994, High accumulative incidence of genital herpes amongst HIV-1 seropositive heterosexuals in south London, Int J STD AIDS, 5, 415, 10.1177/095646249400500607 Heng, 1994, Co-infection and synergy of human immunodeficiency virus-1 and herpes simplex virus-1, Lancet, 343, 255, 10.1016/S0140-6736(94)91110-X Vogel, 1993, Verucous lesions of herpes simplex in HIV-1 patients, Int J Dermatol, 32, 680, 10.1111/j.1365-4362.1993.tb04028.x Monteagudo, 2006, Úlceras herpéticas perianales en un paciente con infección por el virus de inmunodeficiencia humana no diagnosticado previamente, Actas Dermosifiliogr, 97, 479, 10.1016/S0001-7310(06)73448-2 Couppie, 2006, Increased incidence of genital herpes after HAART initiation: a frequent presentation of immune reconstitution inflammatory syndrome (IRIS) in VIH-infected patients, AIDS Patient Care STDS, 20, 143, 10.1089/apc.2006.20.143 Augenbraun, 1995, Increased genital shedding of herpessimplex virus type 2 in HIV-women, Ann Intern Med, 123, 845, 10.7326/0003-4819-123-11-199512010-00006 File, 1994, Recurrence and resistance patterns of herpes simplex virus following cessation of > or = 6 years suppression with acyclovir. Acyclovir Study Group, J Infect Dis, 169, 1338, 10.1093/infdis/169.6.1338 Centers for Disease Control and Prevention, 2002, Sexually transmitted diseases treatment guidelines 2002, MMWR, 51, 1 Snydman, 1999, Infection in solid organ transplantation, Transpl Infect Dis, 1, 21, 10.1034/j.1399-3062.1999.10103.x Dykewicz, 1999, Preventing opportunistic infections in bone marrow transplant recipients, Transpl Infect Dis, 1, 40, 10.1034/j.1399-3062.1999.10105.x Celkan, 2006, Antiviral prophylaxis with continuous low dose acyclovir in childhood cancer, Leuk Lymphoma, 47, 1418, 10.1080/10428190600581682 Reichman, 1983, Topically administered acyclovir in the treatment of recurrent herpes simplex genitalis: a controlled trial, J Infect Dis, 147, 336, 10.1093/infdis/147.2.336 Abbo, 2007, Selective defect in plasmacyoid dendritic cell function in a patient with AIDS-associated atypical genital herpes simplex vegetans treated with imiquimod, Clin Infect Dis, 44, e25, 10.1086/510426 Brummitt, 2006, Imiquimod 5% cream for the treatment of recurrent, acyclovir-resistant genital herpes, Clin Infect Dis, 42, 575, 10.1086/499529 Gilbert, 2001, Topical imiquimod for acyclovir-unresponsive herpes simplex virus 2 infection, Arch Dermatol, 137, 1015 Schacker, 2002, Imiquimod 5-percent cream does not alter the natural history of recurrent herpes genitalis: a phase II, randomized, double-blind, placebo-controlled study, Antimicrob Agents Chemother, 46, 3243, 10.1128/AAC.46.10.3243-3248.2002 Javaly, 1999, Treatment of mucocutaneous herpes simplex virus infections unresponsive to acyclovir with topical foscarnet cream in AIDS patients: a phase I/II study, J Acquir Immune Defic Syndr, 21, 301, 10.1097/00126334-199908010-00007 Ghislanzoni, 2006, Chronic hypertrophic acyclovir-resistant genital herpes treated with topical cidofovir and with topical foscarnet at recurrence in an VIH-positive man, J Eur Acad Dermatol Venereol, 20, 887, 10.1111/j.1468-3083.2006.01561.x Pechere, 1998, Treatment of acyclovir-resistant herpetic ulceration with topical foscarnet and antiviral sensitivity analysis, Dermatology, 197, 278, 10.1159/000018014 Bevilacqua, 1991, Acyclovir resistance/susceptibility in herpessimplex virus type 2 sequential isolates from an AIDS patient, J Acquir Immune Defic Syndr, 4, 967 Waters, 2006, Betadine for herpes simplex infection, Int J STD AIDS, 17, 854, 10.1258/095646206779307487 Palliser, 2006, An si-RNA-based microbicide protects mice from lethal herpes simplex virus 2 infection, Nature, 439, 89, 10.1038/nature04263 Johnson, 2006, Silencing herpes simplex virus with a vaginal microbicide, N Engl J Med, 354, 970, 10.1056/NEJMcibr055613